![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1099-1069|33|3|141-146
ISSN: 0278-0232
Source: Hematological Oncology (Electronic), Vol.33, Iss.3, 2015-09, pp. : 141-146
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fludarabine: A Review of its Use in Non-Hodgkin's Lymphoma
By Anderson Vanessa R. Perry Caroline M.
Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Non-Hodgkin's follicular lymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Economic Burden of Follicular Non-Hodgkin's Lymphoma
By Foster Talia
PharmacoEconomics, Vol. 27, Iss. 8, 2009-08 ,pp. :